Eli Lilly and Company: all 2,262 studies
Page 4 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy ParticipantsCompletedNCT05089019Phase 1Results posted
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT05086445Phase 1Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back PainCompletedNCT05086289Phase 2Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With OsteoarthritisCompletedNCT05080660Phase 2Results posted
- A Study of Baricitinib (LY3009104) in Children With COVID-19TerminatedNCT05074420Phase 3Results posted
- A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy ParticipantsCompletedNCT05069896Phase 1Results posted
- A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes MellitusCompletedNCT05067270Phase 1Results posted
- A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseCompletedNCT05063539Phase 2Results posted
- A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related ComorbiditiesCompletedNCT05051579Phase 2Results posted
- A Multiple Dose Study of LY3502970 in Healthy ParticipantsCompletedNCT05051566Phase 1Results posted
- A Study of LY3502970 in Participants With Type 2 Diabetes MellitusCompletedNCT05048719Phase 2Results posted
- A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)CompletedNCT05024032Phase 3Results posted
- A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Active, not recruitingNCT05023980Phase 3Results posted
- A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 DiabetesCompletedNCT04992312Phase 1Results posted
- A Study of [¹⁴C]-LY3484356 in Healthy Female ParticipantsCompletedNCT04991766Phase 1Results posted
- A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerActive, not recruitingNCT04975308Phase 3Results posted
- A Study of LY3437943 in Participants Who Have Obesity or Are OverweightCompletedNCT04881760Phase 2Results posted
- A Study to Compare Two Different Formulations of Lasmiditan in Healthy ParticipantsCompletedNCT04881747Phase 1Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back PainCompletedNCT04874636Phase 2Results posted
- A Study of LY3437943 in Participants With Type 2 DiabetesCompletedNCT04867785Phase 2Results posted
- A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)CompletedNCT04849416Phase 2Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT TrialCompletedNCT04847557Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Obesity DiseaseCompletedNCT04844918Phase 3Results posted
- A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy ParticipantsCompletedNCT04840901Phase 1Results posted
- A Study of LY3484356 in Healthy Female ParticipantsCompletedNCT04840888Phase 1Results posted
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesCompletedNCT04809220Phase 3Results posted
- A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy ParticipantsCompletedNCT04782076Phase 1Results posted
- A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04760314Phase 3Results posted
- A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerTerminatedNCT04752332Phase 3Results posted
- A Study of Lasmiditan in Healthy VolunteersCompletedNCT04749914Phase 1Results posted
- A Study of Abemaciclib in Indian Women With Advanced Breast CancerCompletedNCT04707196Phase 4Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic PainTerminatedNCT04707157Phase 2Results posted
- A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)CompletedNCT04701658Phase 2Results posted
- A Safety Study of LY3526318 in Healthy ParticipantsCompletedNCT04682119Phase 1Results posted
- A Study of LY3493269 in Healthy ParticipantsCompletedNCT04682106Phase 1Results posted
- A Study of LY3502970 in Healthy Male ParticipantsCompletedNCT04680767Phase 1Results posted
- Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Active, not recruitingNCT04666038Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight LossCompletedNCT04660643Phase 3Results posted
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss ProgramCompletedNCT04657016Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are OverweightCompletedNCT04657003Phase 3Results posted
- Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentActive, not recruitingNCT04647526Phase 3Results posted
- A Study of LY3484356 in Women With Breast Cancer Before Having SurgeryCompletedNCT04647487Phase 1Results posted
- A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)CompletedNCT04640077Phase 2Results posted
- A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 IllnessCompletedNCT04634409Phase 2Results posted
- A Study of LY3462817 in Participants With Rheumatoid ArthritisCompletedNCT04634253Phase 2Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With OsteoarthritisCompletedNCT04627038Phase 2Results posted
- A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)CompletedNCT04626297Phase 3Results posted
- A Study of LY3832479 (LY-CoV016) in Healthy Participants 1CompletedNCT04611789Phase 1Results posted
- A Study of Mirikizumab in Healthy ParticipantsCompletedNCT04607733Phase 1Results posted
- A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)CompletedNCT04605991Phase 3Results posted
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesCompletedNCT04591626Phase 3Results posted
- A Study of LY3509754 in Healthy Non-Japanese and Japanese ParticipantsTerminatedNCT04586920Phase 1Results posted
- A Study of LY900014 and Insulin Degludec in Participants With Type 1 DiabetesCompletedNCT04585776Phase 2Results posted
- A Study of LY3522348 in Healthy ParticipantsCompletedNCT04559568Phase 1Results posted
- A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced CancerTerminatedNCT04557384Phase 1Results posted
- A Study to Compare Two Different Formulations of Mirikizumab in Healthy ParticipantsCompletedNCT04548219Phase 1Results posted
- Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia ATerminatedNCT04541628Phase 1/2Results posted
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without MetforminCompletedNCT04537923Phase 3Results posted
- A Study of LY3819253 (LY-CoV555) in Healthy ParticipantsCompletedNCT04537910Phase 1Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back PainCompletedNCT04529096Phase 2Results posted
- A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisActive, not recruitingNCT04527380Phase 3Results posted
- A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGSTerminatedNCT04517253Phase 2/3Results posted
- A Study of LY3493269 in Participants With Type 2 DiabetesCompletedNCT04515576Phase 1Results posted
- A Study of LY3451838 in Participants With MigraineCompletedNCT04498910Phase 2Results posted
- A Safety Study of LY3493269 in Healthy ParticipantsCompletedNCT04498390Phase 1Results posted
- A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and StaffCompletedNCT04497987Phase 3Results posted
- A Study of Ramucirumab (LY3009806) in Healthy ParticipantsCompletedNCT04495478Phase 1Results posted
- A Study of LY3041658 in Adults With Hidradenitis SuppurativaCompletedNCT04493502Phase 2Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic PainCompletedNCT04476108Phase 2Results posted
- Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427TerminatedNCT04475198Phase 1Results posted
- Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT04474405Early Phase 1Results posted
- Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's DiseaseCompletedNCT04468347Phase 1Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With OsteoarthritisCompletedNCT04456686Phase 2Results posted
- A Study of LY3209590 in Participants With Type 1 DiabetesCompletedNCT04450407Phase 2Results posted
- A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes MellitusCompletedNCT04450394Phase 2Results posted
- A Study of LY3832479 (LY-CoV016) in Healthy ParticipantsCompletedNCT04441931Phase 1Results posted
- A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)Active, not recruitingNCT04437511Phase 3Results posted
- A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 IllnessCompletedNCT04427501Phase 2/3Results posted
- A Study of LY3502970 in Participants With Type 2 DiabetesCompletedNCT04426474Phase 1Results posted
- A Study of Baricitinib (LY3009104) in Participants With COVID-19CompletedNCT04421027Phase 3Results posted
- ADVM-022 Intravitreal Gene Therapy for DMECompletedNCT04418427Phase 2Results posted
- A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19CompletedNCT04411628Phase 1Results posted
- Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate CancerCompletedNCT04408924Phase 2Results posted
- A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using TirzepatideCompletedNCT04407234Phase 1Results posted
- A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedNCT04396574Phase 3Results posted
- A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedNCT04396236Phase 3Results posted
- Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)CompletedNCT04392154Phase 3Results posted
- A Study of LY3127804 in Participants With COVID-19TerminatedNCT04342897Phase 2Results posted
- Study of Tirzepatide in Healthy ParticipantsCompletedNCT04311424Phase 1Results posted
- A Study of Tirzepatide in Overweight and Very Overweight ParticipantsCompletedNCT04311411Phase 1Results posted
- A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP AntagonistCompletedNCT04294147Phase 4Results posted
- A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial SpondyloarthritisCompletedNCT04285229Phase 3Results posted
- A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET ActivationActive, not recruitingNCT04280081Phase 2Results posted
- A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin PumpsCompletedNCT04276207Phase 1Results posted
- A Study of LY3478045 in Healthy ParticipantsCompletedNCT04270370Phase 1Results posted
- A Study of Two Formulations of Ixekizumab in Healthy ParticipantsCompletedNCT04259346Phase 1Results posted
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT04255433Phase 3Results posted
- Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04250350Phase 3Results posted
- Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.CompletedNCT04250337Phase 3Results posted
- A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaCompletedNCT04238819Phase 1/2Results posted